LPL Financial LLC Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

LPL Financial LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 61,581 shares of the company’s stock after purchasing an additional 10,777 shares during the quarter. LPL Financial LLC’s holdings in HCA Healthcare were worth $18,484,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of HCA. Townsquare Capital LLC grew its position in shares of HCA Healthcare by 12.8% in the third quarter. Townsquare Capital LLC now owns 2,687 shares of the company’s stock valued at $1,092,000 after purchasing an additional 305 shares during the last quarter. Glenmede Trust Co. NA increased its position in HCA Healthcare by 4.4% during the third quarter. Glenmede Trust Co. NA now owns 3,022 shares of the company’s stock worth $1,228,000 after buying an additional 128 shares in the last quarter. Rockefeller Capital Management L.P. lifted its position in shares of HCA Healthcare by 1.9% in the third quarter. Rockefeller Capital Management L.P. now owns 23,090 shares of the company’s stock valued at $9,380,000 after acquiring an additional 440 shares in the last quarter. Centiva Capital LP lifted its holdings in HCA Healthcare by 37.4% in the 3rd quarter. Centiva Capital LP now owns 13,264 shares of the company’s stock valued at $5,391,000 after purchasing an additional 3,612 shares in the last quarter. Finally, Holocene Advisors LP grew its holdings in shares of HCA Healthcare by 210.6% during the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after buying an additional 208,015 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Bank of America dropped their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Truist Financial lowered their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, KeyCorp lowered their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $346.08 on Tuesday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The business’s 50-day simple moving average is $325.24 and its 200 day simple moving average is $340.60. The company has a market cap of $85.20 billion, a P/E ratio of 15.75, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business posted $5.90 earnings per share. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.